{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:29Z","timestamp":1707525329269},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,9]]},"DOI":"10.7759\/cureus.46752","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T20:35:25Z","timestamp":1696883725000},"source":"Crossref","is-referenced-by-count":0,"title":["Vaccine Breakthrough Infections Among Healthcare Workers in a COVID-19-Designated Tertiary Care Government Hospital in Sikkim"],"prefix":"10.7759","author":[{"given":"Shrijana","family":"Gurung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekta","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsultem D","family":"Bhutia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tashi P","family":"Chhophel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricca M","family":"Rasaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Sarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birendra","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya D","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruva K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman VM","year":"2018","unstructured":"Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and sources of endemic human coronaviruses. Adv Virus Res. 2018, 100:163-88. 10.1016\/bs.aivir.2018.01.001","journal-title":"Adv Virus Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00790-X","article-title":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study","volume":"397","author":"Hall VJ","year":"2021","unstructured":"Hall VJ, Foulkes S, Saei A, et al.. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021, 397:1725-35. 10.1016\/S0140-6736(21)00790-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00327-2","article-title":"Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases","volume":"6","author":"Kumar VM","year":"2021","unstructured":"Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. NPJ Vaccines. 2021, 6:60. 10.1038\/s41541-021-00327-2","journal-title":"NPJ Vaccines"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00081-5","article-title":"The world's largest COVID-19 vaccination campaign","volume":"21","author":"Bagcchi S","year":"2021","unstructured":"Bagcchi S. The world's largest COVID-19 vaccination campaign. Lancet Infect Dis. 2021, 21:323. 10.1016\/S1473-3099(21)00081-5","journal-title":"Lancet Infect Dis"},{"key":"ref5","unstructured":"Co-Win. GoI. Accessed. September 25, 2023: https:\/\/dashboard.cowin.gov.in\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey M","year":"2021","unstructured":"Voysey M, Costa Clemens SA, Madhi SA, et al.. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021, 397:881-91. 10.1016\/S0140-6736(21)00432-3","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu FC","year":"2020","unstructured":"Zhu FC, Guan XH, Li YH, et al.. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020, 396:479-88. 10.1016\/S0140-6736(20)31605-6","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.07.033","article-title":"Effectiveness of BBV152\/Covaxin and AZD1222\/Covishield vaccines against severe COVID-19 and B.1.617.2\/Delta variant in India, 2021: a multi-centric hospital-based case-control study","volume":"122","author":"Bhatnagar T","year":"2022","unstructured":"Bhatnagar T, Chaudhuri S, Ponnaiah M, et al.. Effectiveness of BBV152\/Covaxin and AZD1222\/Covishield vaccines against severe COVID-19 and B.1.617.2\/Delta variant in India, 2021: a multi-centric hospital-based case-control study. Int J Infect Dis. 2022, 122:693-702. 10.1016\/j.ijid.2022.07.033","journal-title":"Int J Infect Dis"},{"key":"ref9","unstructured":"CDC. COVID-19. Breakthrough cases. https.\/\/www.cdc.gov\/vaccines\/covid-19\/health-departments\/index.html."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2022.100180","article-title":"Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges","volume":"14","author":"Amanatidou E","year":"2022","unstructured":"Amanatidou E, Gkiouliava A, Pella E, et al.. Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges. Metabol Open. 2022, 14:100180. 10.1016\/j.metop.2022.100180","journal-title":"Metabol Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.001","article-title":"Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India","volume":"15","author":"Tyagi K","year":"2021","unstructured":"Tyagi K, Ghosh A, Nair D, Dutta K, Singh Bhandari P, Ahmed Ansari I, Misra A. Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India. Diabetes Metab Syndr. 2021, 15:1007-8. 10.1016\/j.dsx.2021.05.001","journal-title":"Diabetes Metab Syndr"},{"key":"ref12","article-title":"Prevalence and clinical presentation of COVID-19 among healthcare workers at a dedicated hospital in India","volume":"68","author":"Mahajan NN","year":"2020","unstructured":"Mahajan NN, Mathe A, Patokar GA. Prevalence and clinical presentation of COVID-19 among healthcare workers at a dedicated hospital in India. J Assoc Physicians India. 2020, 68:16-21.","journal-title":"J Assoc Physicians India"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1040012","article-title":"SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India","volume":"10","author":"Doke PP","year":"2022","unstructured":"Doke PP, Mhaske ST, Oka G, Kulkarni R, Muley V, Mishra AC, Arankalle VA. SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India. Front Public Health. 2022, 10:1040012. 10.3389\/fpubh.2022.1040012","journal-title":"Front Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1843432","article-title":"COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines","volume":"19","author":"Labetoulle R","year":"2020","unstructured":"Labetoulle R, Detoc M, Gagnaire J, et al.. COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines. Expert Rev Vaccines. 2020, 19:937-47. 10.1080\/14760584.2020.1843432","journal-title":"Expert Rev Vaccines"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2021.10.015","article-title":"Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020-January 2021","volume":"119","author":"Ferland L","year":"2022","unstructured":"Ferland L, Carvalho C, Gomes Dias J, et al.. Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020-January 2021. J Hosp Infect. 2022, 119:170-4. 10.1016\/j.jhin.2021.10.015","journal-title":"J Hosp Infect"},{"key":"ref16","article-title":"The impact of COVID-19 on health and care workers: a closer look at deaths. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/345300. License: CC BY-NC-SA 3.0 IGO","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. The impact of COVID-19 on health and care workers: a closer look at deaths. World Health Organization. WHO, Geneva; 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/345300\/WHO-HWF-WorkingPaper-2021.1-eng.pdf."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_1485_21","article-title":"SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: a retrospective, pilot study","volume":"153","author":"Vaishya R","year":"2021","unstructured":"Vaishya R, Sibal A, Malani A, Prasad KH. SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: a retrospective, pilot study. Indian J Med Res. 2021, 153:550-4. 10.4103\/ijmr.ijmr_1485_21","journal-title":"Indian J Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19070","article-title":"Breakthrough infection with severe acute respiratory syndrome coronavirus 2 among healthcare workers in Delhi: a single-institution study","volume":"13","author":"Sharma P","year":"2021","unstructured":"Sharma P, Mishra S, Basu S, Kumar R, Tanwar N. Breakthrough infection with severe acute respiratory syndrome coronavirus 2 among healthcare workers in Delhi: a single-institution study. Cureus. 2021, 13:e19070. 10.7759\/cureus.19070","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24131","article-title":"Epidemiological characteristics of the COVID-19 pandemic during the first and second waves in Chhattisgarh, Central India: a comparative analysis","volume":"14","author":"Agarwala P","year":"2022","unstructured":"Agarwala P, Bhargava A, Gahwai DK, Negi SS, Shukla P, Dayama S. Epidemiological characteristics of the COVID-19 pandemic during the first and second waves in Chhattisgarh, Central India: a comparative analysis. Cureus. 2022, 14:e24131. 10.7759\/cureus.24131","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-022-01001-3","article-title":"Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape","volume":"68","author":"Bhattacharya M","year":"2023","unstructured":"Bhattacharya M, Chatterjee S, Sharma AR, Lee SS, Chakraborty C. Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape. Folia Microbiol (Praha). 2023, 68:17-28. 10.1007\/s12223-022-01001-3","journal-title":"Folia Microbiol (Praha)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/v13091782","article-title":"Clinical characterization and genomic analysis of samples from COVID-19 breakthrough infections during the second wave among the various states of India","volume":"13","author":"Gupta N","year":"2021","unstructured":"Gupta N, Kaur H, Yadav PD, et al.. Clinical characterization and genomic analysis of samples from COVID-19 breakthrough infections during the second wave among the various states of India. Viruses. 2021, 13:1782. 10.3390\/v13091782","journal-title":"Viruses"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08097-z","article-title":"Clinical features and severe outcome predictors of COVID-19 vaccine breakthrough infection among hospitalized patients: results from Egypt severe acute respiratory infections sentinel surveillance, 2021-2022","volume":"23","author":"Kandeel A","year":"2023","unstructured":"Kandeel A, Fahim M, Deghedy O, et al.. Clinical features and severe outcome predictors of COVID-19 vaccine breakthrough infection among hospitalized patients: results from Egypt severe acute respiratory infections sentinel surveillance, 2021-2022. BMC Infect Dis. 2023, 23:130. 10.1186\/s12879-023-08097-z","journal-title":"BMC Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000946","article-title":"Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India","volume":"3","author":"Rahi M","year":"2023","unstructured":"Rahi M, Yadav CP, Ahmad SS, et al.. Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. PLOS Glob Public Health. 2023, 3:e0000946. 10.1371\/journal.pgph.0000946","journal-title":"PLOS Glob Public Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40009-022-01106-w","article-title":"SARS-CoV-2 infection after vaccination in Italian health care workers: a case report","volume":"45","author":"Cafiero C","year":"2022","unstructured":"Cafiero C, Palmirotta R, Micera A, et al.. SARS-CoV-2 infection after vaccination in Italian health care workers: a case report. Natl Acad Sci Lett. 2022, 45:249-54. 10.1007\/s40009-022-01106-w","journal-title":"Natl Acad Sci Lett"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.23749\/mdl.v111i3.9767","article-title":"COVID-19 infection and diffusion among the healthcare workforce in a large university-hospital in northwest Italy","volume":"111","author":"Garzaro G","year":"2020","unstructured":"Garzaro G, Clari M, Ciocan C, et al.. COVID-19 infection and diffusion among the healthcare workforce in a large university-hospital in northwest Italy. Med Lav. 2020, 111:184-94. 10.23749\/mdl.v111i3.9767","journal-title":"Med Lav"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2541_20","article-title":"SARS COV 2 positive healthcare workers in obstetrics and gynaecology- save the saviour study","volume":"10","author":"Marwah S","year":"2021","unstructured":"Marwah S, Arora R, Sivajyothi BM, Dhama V, Gupta N. SARS COV 2 positive healthcare workers in obstetrics and gynaecology- save the saviour study. J Family Med Prim Care. 2021, 10:4410-7. 10.4103\/jfmpc.jfmpc_2541_20","journal-title":"J Family Med Prim Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.3996","article-title":"Symptomatic and asymptomatic viral shedding in pediatric patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): under the surface","volume":"175","author":"DeBiasi RL","year":"2021","unstructured":"DeBiasi RL, Delaney M. Symptomatic and asymptomatic viral shedding in pediatric patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): under the surface. JAMA Pediatr. 2021, 175:16-8. 10.1001\/jamapediatrics.2020.3996","journal-title":"JAMA Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.2767","article-title":"Yes, children can transmit COVID, but we need not fear","volume":"175","author":"Coffin SE","year":"2021","unstructured":"Coffin SE, Rubin D. Yes, children can transmit COVID, but we need not fear. JAMA Pediatr. 2021, 175:1110-2. 10.1001\/jamapediatrics.2021.2767","journal-title":"JAMA Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.idh.2021.06.002","article-title":"COVID-19 personal protective equipment protocol compliance audit","volume":"26","author":"Wotherspoon S","year":"2021","unstructured":"Wotherspoon S, Conroy S. COVID-19 personal protective equipment protocol compliance audit. Infect Dis Health. 2021, 26:273-5. 10.1016\/j.idh.2021.06.002","journal-title":"Infect Dis Health"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.22-0172","article-title":"Determinants of COVID-19 breakthrough infections and severity in ChAdOx1 nCoV-19-vaccinated priority groups","volume":"107","author":"Kaur U","year":"2022","unstructured":"Kaur U, Bala S, Ojha B, et al.. Determinants of COVID-19 breakthrough infections and severity in ChAdOx1 nCoV-19-vaccinated priority groups. Am J Trop Med Hyg. 2022, 107:850-5. 10.4269\/ajtmh.22-0172","journal-title":"Am J Trop Med Hyg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191848-vaccine-breakthrough-infections-among-healthcare-workers-in-a-covid-19-designated-tertiary-care-government-hospital-in-sikkim","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:06Z","timestamp":1707509466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191848-vaccine-breakthrough-infections-among-healthcare-workers-in-a-covid-19-designated-tertiary-care-government-hospital-in-sikkim"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.46752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}